Diluent

DRUG11 trials

Conditions

Amyotrophic Lateral Sclerosis (ALS)AnhedoniaAtopic AsthmaBipolar DisorderDetection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2HIVHealthyIntranasal Insulin

Phase 1

Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge

TerminatedNCT00671593

John SundyAtopic Asthma, Healthy

Start: 2006-10-31End: 2009-04-30Updated: 2013-07-16

Brain Insulin Resistance in Mood Disorders

NCT03915613

University Health Network, TorontoAnhedonia, Bipolar Disorder, Intranasal Insulin +1

Start: 2021-10-06End: 2024-10-05Target: 150Updated: 2023-12-15

A study to assess a new Lassa Virus Vaccine in healthy volunteers

Active, not recruitingPACTR202108781239363

Emergent Product Development Gaithersburg IncLassa Fever

Start: 2022-03-31Target: 108Updated: 2026-01-27

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

TerminatedNCT05216510

Tonix Pharmaceuticals, Inc.Detection of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 in Individuals Exposed to SARS-CoV-2

Start: 2022-01-07End: 2022-09-17Updated: 2024-11-06

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

RecruitingNCT06351592

Regeneron PharmaceuticalsAmyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene

Start: 2024-08-28End: 2031-06-05Target: 42Updated: 2026-02-27

A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

RecruitingNCT06660667

SanofiNeovascular Age-related Macular Degeneration

Start: 2024-11-21End: 2031-06-30Target: 66Updated: 2025-11-21

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

RecruitingNCT06796686

National Institute of Allergy and Infectious Diseases (NIAID)HIV

Start: 2025-03-17End: 2027-01-15Target: 42Updated: 2025-09-25

Phase 2

A Phase 2 Lassa fever vaccine trial in adults and children residing in West Africa.

RecruitingPACTR202210840719552

IAVILassa Fever

Start: 2023-08-01Target: 612Updated: 2026-01-27

Phase 3

The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder

CompletedNCT00314314

University Health Network, TorontoBipolar Disorder

Start: 2006-05-31End: 2009-03-31Target: 60Updated: 2009-07-13

Sildenofil in Persistent Pulmonary Hypertension in Newborns

NCT01558466

Hamad Medical CorporationPersistent Fetal Circulation Syndrome

Start: 2011-11-30End: 2015-06-30Target: 100Updated: 2012-09-25

Phase 4

Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls

CompletedNCT01862523

Universitaire Ziekenhuizen KU LeuvenRhinitis

Start: 2012-02-29End: 2014-12-31Updated: 2014-12-05

Related Papers

GMP Manufacturing and Characterization of the HIV Booster Immunogen HxB2.WT.Core-C4b for Germline Targeting Vaccine Strategies

Vaccines2025-09-18